Institutional Ownership Karyopharm Therapeutics Inc. (KPTI)
This table provides information about the institutional ownership of Karyopharm Therapeutics Inc. (KPTI). We have compiled data on the 98 institutions that hold shares in the stock, with a total of 57.6 Million shares, which have been reported (via 13F filing form) to have a value of $37.4 Million.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Vanguard Group Inc
Valley Forge, PA |
Nov 13, 2024 Q3 2024 |
7,654,482
shares
|
$4.9 Million
0.0% of portfolio
|
Q2 2024
Reduced 8.2%
|
|
|
Eversept Partners, LP
New York, NY |
Nov 14, 2024 Q3 2024 |
5,547,880
shares
|
$3.55 Million
0.36% of portfolio
|
Q3 2024
Added 11.24%
|
|
|
Palo Alto Investors LP
Palo Alto, CA |
Nov 14, 2024 Q3 2024 |
5,102,193
shares
|
$3.27 Million
0.58% of portfolio
|
Q4 2023
Reduced 10.11%
|
|
|
Adage Capital Partners Gp, L.L.C.
Boston, MA |
Nov 14, 2024 Q3 2024 |
4,319,842
shares
|
$2.76 Million
0.01% of portfolio
|
Q2 2024
Added 23.42%
|
|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
4,169,788
shares
|
$2.67 Million
0.0% of portfolio
|
Q2 2024
Reduced 55.86%
|
|
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
Nov 14, 2024 Q3 2024 |
3,103,669
shares
|
$1.99 Million
0.0% of portfolio
|
Q3 2024
Added 0.07%
|
|
|
Marshall Wace, LLP
London, X0 |
Nov 14, 2024 Q3 2024 |
2,082,226
shares
|
$1.33 Million
0.0% of portfolio
|
Q3 2024
Reduced 19.32%
|
|
|
Avidity Partners Management LP
Dallas, TX |
Nov 14, 2024 Q3 2024 |
2,018,500
shares
|
$1.29 Million
0.1% of portfolio
|
Q2 2024
Reduced 75.68%
|
|
|
Gsa Capital Partners LLP
London, X0 |
Nov 05, 2024 Q3 2024 |
1,775,700
shares
|
$1.14 Million
0.11% of portfolio
|
Q3 2024
Added 80.56%
|
|
|
C World Wide Group Holding A
|
Nov 05, 2024 Q3 2024 |
1,500,000
shares
|
$960,000
0.01% of portfolio
|
Q4 2021
Added 25.0%
|
|
|
Jpmorgan Chase & CO
New York, NY |
Nov 08, 2024 Q3 2024 |
1,385,724
shares
|
$886,863
0.0% of portfolio
|
Q3 2024
Added 8.61%
|
|
|
Geode Capital Management, LLC
Boston, MA |
Nov 12, 2024 Q3 2024 |
1,355,392
shares
|
$867,450
0.0% of portfolio
|
Q3 2024
Added 3.34%
|
|
|
Goldman Sachs Group Inc
New York, NY |
Nov 14, 2024 Q3 2024 |
1,336,715
shares
|
$855,497
0.0% of portfolio
|
Q3 2024
Reduced 41.64%
|
|
|
Deutsche Bank Ag\
Frankfurt Am Main, 2M |
Nov 13, 2024 Q3 2024 |
1,268,777
shares
|
$812,017
0.0% of portfolio
|
Q2 2024
Reduced 4.24%
|
|
|
Israel Englander
Millennium Management LLC | New York, Ny
|
Nov 14, 2024 Q3 2024 |
1,255,264
shares
|
$803,368
0.0% of portfolio
|
Q3 2024
Reduced 40.01%
|
|
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
Nov 13, 2024 Q3 2024 |
1,241,407
shares
|
$794,500
0.0% of portfolio
|
Q3 2024
Added 64.16%
|
|
|
Kennedy Capital Management, Inc.
St Louis, MO |
Nov 14, 2024 Q3 2024 |
1,204,009
shares
|
$770,565
0.02% of portfolio
|
Q3 2024
Added 0.6%
|
|
|
Ubs Oconnor LLC
Chicago, IL |
Nov 14, 2024 Q3 2024 |
1,196,174
shares
|
$765,551
0.07% of portfolio
|
Q3 2024
Added 8.51%
|
|
|
Alpha Centric Advisors LLC
San Juan, PR |
Oct 30, 2024 Q3 2024 |
1,125,000
shares
|
$720,000
0.79% of portfolio
|
Q3 2023
Added 38.89%
|
|
|
D. E. Shaw & Co., Inc.
New York, NY |
Nov 14, 2024 Q3 2024 |
1,047,396
shares
|
$670,333
0.0% of portfolio
|
Q3 2024
Added 24.08%
|
|
|
Altium Capital Management LP
New York, NY |
Nov 14, 2024 Q3 2024 |
740,000
shares
|
$473,600
0.22% of portfolio
|
Q2 2023
Added 46.31%
|
|
|
Silverarc Capital Management, LLC
|
Nov 14, 2024 Q3 2024 |
558,466
shares
|
$357,418
0.12% of portfolio
|
Q1 2024
Reduced 0.62%
|
|
|
Macquarie Group LTD
Australia, C3 |
Nov 14, 2024 Q3 2024 |
500,000
shares
|
$320,000
0.0% of portfolio
|
Q3 2024
Reduced 1.12%
|
|
|
Cubist Systematic Strategies, LLC
Stamford, CT |
Nov 14, 2024 Q3 2024 |
496,236
shares
|
$317,591
0.0% of portfolio
|
Q3 2024
Reduced 12.78%
|
|
|
Birchview Capital, LP
Burlington, VT |
Nov 14, 2024 Q3 2024 |
469,832
shares
|
$300,692
0.36% of portfolio
|
Q1 2024
Reduced 17.84%
|